TWD 18.95
(-26.41%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 43.49 Million TWD | -76.92% |
2022 | 188.41 Million TWD | 71.56% |
2021 | 109.82 Million TWD | 380.08% |
2020 | 22.87 Million TWD | 1076.75% |
2019 | 1.94 Million TWD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q1 | 10.16 Million TWD | -33.34% |
2024 Q2 | 16.6 Million TWD | 63.37% |
2023 Q1 | 6.5 Million TWD | -86.5% |
2023 Q3 | 15.24 Million TWD | 134.57% |
2023 FY | 43.49 Million TWD | -76.92% |
2023 Q4 | 15.24 Million TWD | 0.0% |
2023 Q2 | 6.5 Million TWD | 0.0% |
2022 Q3 | 48.16 Million TWD | 0.0% |
2022 FY | 188.41 Million TWD | 71.56% |
2022 Q4 | 48.16 Million TWD | 0.0% |
2021 FY | 109.82 Million TWD | 380.08% |
2020 FY | 22.87 Million TWD | 1076.75% |
2019 FY | 1.94 Million TWD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Anti-Microbial Savior BioteQ Co., Ltd | 728 Thousand TWD | -5874.451% |
SYN-TECH Chem. & Pharm. Co., Ltd. | 1.11 Billion TWD | 96.098% |
Level Biotechnology Inc. | 660.61 Million TWD | 93.416% |
Sagittarius Life Science Corp | 440.46 Million TWD | 90.125% |
NeoCore Technology Co., Ltd. | 64.72 Million TWD | 32.806% |
TaiMed Biologics Inc. | 491.77 Million TWD | 91.156% |
GlycoNex Incorporation | 2.54 Million TWD | -1611.015% |
VBI | 55.85 Million TWD | 22.128% |
GeneReach Biotechnology Corp. | 225.46 Million TWD | 80.709% |
Taiwan Advance Bio-Pharmaceutical Inc. | 315.98 Million TWD | 86.235% |
SynCore Biotechnology Co.,Ltd | 20.19 Million TWD | -115.359% |
Genomics BioSci & Tech. Co.,Ltd. | 396.14 Million TWD | 89.021% |
Visgeneer Inc. | 147.99 Million TWD | 70.611% |
Mycenax Biotech Inc. | 652.62 Million TWD | 93.335% |
Sunmax Biotechnology Co., Ltd. | 1.68 Billion TWD | 97.425% |
G&E Herbal Biotechnology Co., Ltd. | 181.44 Million TWD | 76.029% |
Neith Corporation | 39.9 Million TWD | -8.999% |
Medigen Vaccine Biologics Corporation | 389.62 Million TWD | 88.837% |
TaiwanJ Pharmaceuticals Co., Ltd. | 22.74 Million TWD | -91.25% |
TaiRx, Inc. | 5.08 Million TWD | -755.844% |
CHO Pharma, Inc. | - TWD | -Infinity% |
EirGenix Inc. | 1.02 Billion TWD | 95.747% |
BioLASCO Taiwan Co., Ltd. | 264.72 Million TWD | 83.57% |
Sunny Pharmtech Inc. | 428.82 Million TWD | 89.857% |
Lin BioScience, Inc. | - TWD | -Infinity% |
BioGend Therapeutics Co., Ltd. | 109.9 Million TWD | 60.427% |
Feng Chi Biotech Corp. | 180.57 Million TWD | 75.914% |
Bio Preventive Medicine Corp. | 1.2 Million TWD | -3500.497% |
Lukas Biomedical Inc. | 231.83 Million TWD | 81.239% |
RBC Bioscience Corporation | 172.46 Million TWD | 74.781% |
BiOptic Inc. | 228.26 Million TWD | 80.946% |
BRIM Biotechnology, Inc. | 90 Thousand TWD | -48226.667% |
Shine-On BioMedical Co.,Ltd. | 9.52 Million TWD | -356.678% |
Great Novel Therapeutics Biotech & Medicals | 4.85 Million TWD | -796.784% |
Syngen Biotech Co.,Ltd. | 1.83 Billion TWD | 97.633% |
Advagene Biopharma Co., Ltd. | - TWD | -Infinity% |
NaviFUS Corp. | 22.48 Million TWD | -93.47% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 141.17 Million TWD | 69.192% |
Sinew Pharma Inc. | - TWD | -Infinity% |
Andros Pharmaceuticals Co.,Ltd | 805 Thousand TWD | -5302.981% |
Greenyn Biotechnology Co., Ltd | 800.51 Million TWD | 94.567% |
Lumosa Therapeutics Co., Ltd. | 56.91 Million TWD | 23.582% |
AP Biosciences Inc | 32.25 Million TWD | -34.853% |
Medigen Biotechnology Corp. | 1.15 Billion TWD | 96.243% |
3D Global Biotech Inc. | 20.63 Million TWD | -110.798% |
Pharmosa Biopharm Inc. | 314.5 Million TWD | 86.17% |
Intech Biopharm Corporation | 25.84 Million TWD | -68.275% |
Oneness Biotech Co., Ltd. | 86.78 Million TWD | 49.882% |
Eusol Biotech Co.,Ltd. | - TWD | -Infinity% |
TWi Biotechnology, Inc. | - TWD | -Infinity% |
Ever Supreme Bio Technology Co., Ltd | 758.39 Million TWD | 94.265% |
TCI GENE Inc. | 333.85 Million TWD | 86.972% |
MegaPro Biomedical Co., Ltd | 18 Thousand TWD | -241533.333% |
Senhwa Biosciences, Inc. | 1 Million TWD | -4249.4% |
Taiwan Bio Therapeutics Co., Ltd | 85.47 Million TWD | 49.112% |
NatureWise Biotech & Medicals Corporation | 160.14 Million TWD | 72.84% |
PharmaEngine, Inc. | 767.66 Million TWD | 94.334% |
Savior Lifetec Corporation | 1.05 Billion TWD | 95.859% |
TaiGen Biopharmaceuticals Holdings Limited | 123.13 Million TWD | 64.678% |
OBI Pharma, Inc. | 41.54 Million TWD | -4.681% |
Meribank Biotech Co., Ltd | 234.34 Million TWD | 81.44% |
Acepodia, Inc. | 16.59 Million TWD | -162.123% |
Caliway Biopharmaceuticals Co., Ltd. | 38.93 Million TWD | -11.718% |